Related Experiment Video
Updated: Aug 5, 2026

Revealing the Ferroptotic Phenotype of Medulloblastoma
Published on: March 15, 2024
Pathogenesis and role of ferroptosis mediated by Nrf2 signaling pathway in ischemic stroke
Nitong Ying1, Yongyan Wang1, Zirong Li1
1Department of Human Anatomy, Medical School, Kunming University of Science and Technology, Kunming, 650500, PR China.
Abstract:
Ferroptosis, a novel mode of programmed cell death, plays a significant role in neurological injury following ischemic stroke (IS). Nuclear factor E2-related factor 2 (Nrf2), a central transcription factor that combats oxidative stress, is a critical target for inhibiting ferroptosis by modulating iron metabolism, lipid peroxidation, and the glutathione system. In this paper, we systematically review the molecular mechanisms, signaling pathways, and potential therapeutic strategies, including pharmacological activators like dimethyl fumarate (DMF), natural compounds, and nanotechnology-based delivery systems, associated with the Nrf2 signaling pathway in the regulation of ferroptosis after cerebral ischemic injury. Additionally, we highlight future research directions, such as the development of targeted Nrf2 activators and investigations into cell-type-specific responses to ferroptosis modulation. This review underscores the therapeutic potential of Nrf2 signaling in IS while advocating for precision medicine approaches to address its dualistic challenges.
Insights
Nuclear factor E2-related factor 2 (Nrf2) signaling regulates ferroptosis, a cell death form impacting ischemic stroke (IS) neurological injury. Targeting Nrf2 offers therapeutic potential for IS by modulating oxidative stress and cell death pathways.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Ferroptosis is a programmed cell death form implicated in neurological damage after ischemic stroke (IS).
- Nuclear factor E2-related factor 2 (Nrf2) is a key regulator of cellular responses to oxidative stress.
- Nrf2 influences iron metabolism, lipid peroxidation, and glutathione pathways, all relevant to ferroptosis.
Purpose of the Study:
- To systematically review the molecular mechanisms and signaling pathways of Nrf2 in regulating ferroptosis post-cerebral ischemic injury.
- To explore potential therapeutic strategies targeting the Nrf2 pathway for IS treatment.
- To identify future research directions in Nrf2-mediated ferroptosis modulation.
Main Methods:
- Systematic literature review focusing on Nrf2 signaling, ferroptosis, and cerebral ischemia.
- Analysis of molecular mechanisms, signaling pathways, and therapeutic interventions.
- Identification of research gaps and future prospects.
Main Results:
- Nrf2 is a critical target for inhibiting ferroptosis by modulating key metabolic pathways.
- Pharmacological activators (e.g., dimethyl fumarate), natural compounds, and nanotechnology show promise in Nrf2-based therapies.
- Nrf2 signaling presents therapeutic potential but requires precision medicine approaches due to its complexity.
Conclusions:
- The Nrf2 signaling pathway is a significant regulator of ferroptosis in the context of ischemic stroke.
- Targeting Nrf2 offers a promising therapeutic avenue for mitigating neurological injury.
- Further research into targeted Nrf2 activators and cell-type-specific responses is warranted for effective clinical translation.
Related Concept Videos
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology